Costs of syringe vending machines in Tbilisi, Georgia

Syringe vending machines (SVM) can improve access to sterile injecting equipment, but they have not been widely implemented or evaluated. We evaluate the cost of SVM installed between July 2019-December 2020 in Tbilisi, Georgia. The SVM were stocked with several kit types, including injecting equipm...

Full description

Saved in:
Bibliographic Details
Published in:Harm reduction journal 2023-08, Vol.20 (1), p.103-8, Article 103
Main Authors: Walker, Josephine G, Kirtadze, Irma, Tabatadze, Mzia, Vickerman, Peter, Otiashvili, David
Format: Article
Language:English
Subjects:
Analgesics, Opioid
Analysis
Caucacus
Condoms
Costs
Dispensing
Drugs
Equipment costs
Expenditures
Female
Focus groups
Funding
Georgia (Republic)
Harm reduction
Health aspects
Hepatitis C
Humans
Hypodermic needles
Hypodermic syringes
Male
Medical care, Cost of
Naloxone
Narcotics
Needle and syringe provision
Needle-Exchange Programs
Opioids
Overhead costs
People who inject drugs
Pharmacy
Prices and rates
Real estate sales
Start up
Stimulants
Substance Abuse, Intravenous
Syringes
Vending machines
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Syringe vending machines (SVM) can improve access to sterile injecting equipment, but they have not been widely implemented or evaluated. We evaluate the cost of SVM installed between July 2019-December 2020 in Tbilisi, Georgia. The SVM were stocked with several kit types, including injecting equipment for opioid or stimulant users, naloxone, male and female condoms, and pregnancy tests. We gathered financial data from the project to estimate fixed (staff time, start-up costs, equipment, running costs, and consumables) and variable (harm reduction kits) costs. We calculated the full cost of the SVM intervention, cost per user, cost per additional syringe accessed by SVM users, and cost per kit distributed (2020 Euros). SVM access cards were issued to 1132 users, and 29,238 kits were distributed through SVM, total cost €204,358. Staff costs were 51% of total, consumable costs 28%, equipment 10%, and start up, recurrent costs, and overheads 5% or less each. Opioid and stimulant kits were most accessed (35% and 32% of total). Cost per user was €66/year, and cost per transaction €7, of which €5 fixed costs and €2 variable. If monthly transactions increased from the average of 1622/month to highest monthly usage (4714), fixed costs per transaction would decrease to 
ISSN:1477-7517
1477-7517
DOI:10.1186/s12954-023-00829-3